Table 7.

Discrete choice model of association between GI events and receipt of bisphosphonate treatment (versus non-bisphosphonate)^a

Effect	Estimated odds ratio	95 % CI	p value
Pre-index GI event (ref: no pre-index GI event)	0.846	(0.74, 0.95)	0.0009
Post-index GI event (ref: no post-index GI event)	0.654	(0.57, 0.74)	<0.0001
Age group
65–74 vs. 55–64	0.962	(0.87, 1.06)	0.0613
75–84 vs. 55–64	0.785	(0.71, 0.87)	0.0023
85+ vs. 55–64	0.720	(0.54, 0.97)	0.0624
Pre-index Medication Use
Gastro-protective agents	0.684	(0.62, 0.76)	<0.0001
NSAIDs	1.066	(0.97, 1.17)	0.1835
Glucocorticoids	0.982	(0.88, 1.09)	0.7334
Charlson comorbidity index score	0.961	(0.92, 1.01)	0.0963

NSAIDs non-steroidal anti-inflammatory drugs

^aAmong patients who initiated treatment

CI confidence interval